Burnham & Co »

Vaneck Vectors Pharmaceutical etf shares owned by Burnham & Co

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Burnham & Co from 13F filings

Historical chart of Burnham & Co investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by Burnham & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Burnham & Co

Quarter filed Position value Share count Share price at filing
2026-06-30 $44k 400 109.35

More positions owned by Burnham & Co

Eli Lilly & Co. (LLY)
Centrus Energy Corp Cl A (LEU)
Icon Pub SHS (ICLR)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Goldman Sachs Etf Tr Ultr Shor Bd Etf (GSST)
Apple (AAPL)
HNI Corporation (HNI)
United Parcel Svcs CL B (UPS)
Stryker Corporation (SYK)
Alphabet Cap Stk Cl A (GOOGL)
Abbvie (ABBV)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Constellation Energy (CEG)

View all positions for Burnham & Co

Top funds holding Vaneck Vectors Pharmaceutical etf

Goldman Sachs Group
Jane Street
Healthcare Of Ontario Pension Plan Trust Fund
Bnp Paribas Arbitrage, Snc
British Columbia Investment Management Corporation
Employees Retirement System of Texas
Royal Bank of Canada
J.Safra Asset Management
Avalon Trust
Citigroup
Gts Securities
Morgan Stanley
Adamsbrown Wealth Consultants
Bank of America Corporation
Miller Investment Management

View all funds holding Vaneck Vectors Pharmaceutical etf